Ticker name:AMRNAMARIN CORP PLCUK
Country: IE-Sector: Healthcare, Industry: Biotechnology
Amarin Corporation plc is a pharmaceutical firm dedicated to the research, development, and commercialization of therapeutic solutions for cardiovascular diseases. Its operations span several international regions, including the United States, Germany, Canada, Lebanon, and the United Arab Emirates. The company's flagship product is VASCEPA, an omega-3 fatty acid formulation available by prescription only. This medication acts as an adjunctive therapy to diet, designed to decrease elevated triglyceride levels in adult patients suffering from severe hypertriglyceridemia. Amarin primarily distributes its offerings through wholesale channels and specialized pharmacy providers. Furthermore, the company has entered into a collaboration with Mochida Pharmaceutical Co., Ltd. to advance the development and market introduction of drug products and new indications derived from Vascepa's active pharmaceutical ingredient, which encompasses omega-3 acid and eicosapentaenoic acid. Established in 1989 as Ethical Holdings plc, the organization rebranded to Amarin Corporation plc in 1999. Its corporate headquarters are located in Dublin, Ireland.
- CEO: Aaron D. Berg
- IPO: Apr 01, 1993
- Website:amarincorp.com (open a new tab)
Market Cap 253M
Last close 12.25$
Floor clearance 8.22%
Price Return
- 90d
- -14.1%
- YTD
- -12.22%
- 1Y
- -19.41%
- 3Y
- -20.99%
- 5Y
- -85.02%
Key metrics
Largest 20 companies In Biotechnology
| # Position | Ticker | Company Name | Market Cap | Last Price | Action |
|---|---|---|---|---|---|
| 1 | VRTX | VERTEX PHARMACEUTICALS INC / MA | 139B | 549.04$ | |
| 2 | MRNA | Moderna, Inc. | 103B | 258.38$ | |
| 3 | REGN | REGENERON PHARMACEUTICALS, INC. | 96B | 930.67$ | |
| 4 | RVMD | Revolution Medicines, Inc. | 43B | 199.7$ | |
| 5 | GMAB | GENMAB A/S | 34B | 55.12$ | |
| 6 | ROIV | Roivant Sciences Ltd. | 28B | 38.23$ | |
| 7 | UTHR | UNITED THERAPEUTICS Corp | 26B | 608.49$ | |
| 8 | INCY | INCYTE CORP | 25B | 122.85$ | |
| 9 | INSM | INSMED Inc | 24B | 110$ | |
| 10 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | 22B | 161.08$ | |
| 11 | EXEL | EXELIXIS, INC. | 18B | 72.75$ | |
| 12 | ASND | Ascendis Pharma A/S | 17B | 257.93$ | |
| 13 | NBIX | NEUROCRINE BIOSCIENCES INC | 17B | 166.05$ | |
| 14 | BBIO | BridgeBio Pharma, Inc. | 15B | 77.89$ | |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 15B | 234.66$ | |
| 16 | HALO | HALOZYME THERAPEUTICS, INC. | 15B | 130.34$ | |
| 17 | SMMT | Summit Therapeutics Inc. | 13B | 16.17$ | |
| 18 | KYMR | Kymera Therapeutics, Inc. | 12B | 136.25$ | |
| 19 | TECH | BIO-TECHNE Corp | 11B | 72.73$ | |
| 20 | BMRN | BIOMARIN PHARMACEUTICAL INC | 11B | 57.13$ |